| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |